NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results

Net product revenue of $4.6 million increased 26% over the prior-year quarter



Wound care sales of $1.3 million mark a record quarterly high



Sales and marketing expenses reduced by 16% through...
-Today at 04:15 pm- MarketScreener

Related Keywords

United States ,China ,Canada ,American ,Justin Hall ,Novabay Avenova ,Pioneer Pharma Hong Kong Company Ltd ,Twitter ,Novabay Pharmaceuticals Inc ,Exchange Commission ,Novabay Pharmaceuticals ,Pharmaceuticals Inc ,Facebook ,Bay Pharmaceuticals ,Antimicrobial Lid ,Flash Solution ,Pioneer Pharma ,Hong Kong ,Private Securities Litigation Reform Act ,Stay Informed ,Purchasing Information ,Markets ,